Skip to main content
SpringerLink
Log in

Screening and Secondary Prevention

  • Chapter
  • First Online:
Chronic Illness Care

  • 703 Accesses

Abstract

Screening and secondary prevention are important components of chronic illness care, which have a goal of detecting and preventing the onset of disease, as well as preventing or mitigating the progression of disease morbidity and mortality. There are several principles that inform screening, different types of screening, in addition to risks and benefits. Clinicians need to understand the evidence criteria for screening, as well as barriers and challenges to implementing screening in practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Whitby LG. Screening for disease: definitions and criteria. Lancet. 1974;2(7884):819–22.

    Article  CAS  PubMed  Google Scholar 

  2. WHO/Europe | Publications – Screening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm [Internet]. 2020 [cited 2022 Jan 30]. https://www.euro.who.int/en/publications/abstracts/screening-programmes-a-short-guide.-increase-effectiveness,-maximize-benefits-and-minimize-harm-2020.

  3. Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Akobeng AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2007;96(3):338–41.

    Article  PubMed  Google Scholar 

  5. Prevalence | epidemiology | Britannica [Internet]. [cited 2021 Sep 7]. https://www.britannica.com/science/prevalence.

  6. Mausner JS, Kramer S. Epidemiology: an introductory text. Philadelphia: Saunders; 1985.

    Google Scholar 

  7. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam. 1968;65(4):281–393.

    CAS  PubMed  Google Scholar 

  8. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564–75.

    Article  Google Scholar 

  9. Verma M, Sarfaty M, Brooks D, Wender RC. Population-based programs for increasing colorectal cancer screening in the United States. CA Cancer J Clin. 2015;65(6):497–510.

    Article  PubMed  Google Scholar 

  10. Dougherty MK, Brenner AT, Crockett SD, Gupta S, Wheeler SB, Coker-Schwimmer M, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(12):1645–58.

    Article  PubMed  PubMed Central  Google Scholar 

  11. US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, et al. Screening for prostate cancer: US preventive services task force recommendation statement. JAMA. 2018;319(18):1901–13.

    Article  Google Scholar 

  12. Kilpeläinen TP, Tammela TLJ, Roobol M, Hugosson J, Ciatto S, Nelen V, et al. False-positive screening results in the European randomized study of screening for prostate cancer. Eur J Cancer. 2011;47(18):2698–705.

    Article  PubMed  Google Scholar 

  13. Benefits and risks of screening tests – InformedHealth.org – NCBI Bookshelf [Internet]. 2019 [cited 2022 Jan 31]. https://www.ncbi.nlm.nih.gov/books/NBK279418/.

  14. US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(10):949–56.

    Article  Google Scholar 

  15. Kaysin A, Gourlay ML. Screening for chronic disease. In: Daaleman TP, Helton MR, editors. Chronic illness care. Cham: Springer International Publishing; 2018. p. 163–73.

    Chapter  Google Scholar 

  16. Kapp JM, Yankaskas BC, LeFevre ML. Are mammography recommendations in women younger than 40 related to increased risk? Breast Cancer Res Treat. 2010;119(2):485–90.

    Article  PubMed  Google Scholar 

  17. Harris RP, Wilt TJ, Qaseem A, High Value Care Task Force of the American College of Physicians. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162(10):712–7.

    Article  PubMed  Google Scholar 

  18. Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl P-H. Breast cancer screening in Denmark. Ann Intern Med. 2017;167(7):524.

    Article  PubMed  Google Scholar 

  19. Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015;175(2):274–86.

    Article  PubMed  Google Scholar 

  20. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13.

    Article  PubMed  Google Scholar 

  21. Gupta P, Gupta M, Koul N. Overdiagnosis and overtreatment; how to deal with too much medicine. J Family Med Prim Care. 2020;9(8):3815–9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gates TJ. Screening for cancer: concepts and controversies. Am Fam Physician. 2014;90(9):625–31.

    PubMed  Google Scholar 

  23. Screening Programmes: a short guide. [cited 2021 Sep 13]. https://apps.who.int/iris/bitstream/handle/10665/330829/9789289054782-eng.pdf.

  24. Procedure Manual Section 2. Topic selection, prioritization, and updating | United States Preventive Services Taskforce [Internet]. [cited 2021 Sep 13]. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-2-topic-selection-prioritization-and-updating.

  25. US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for pancreatic cancer: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2019;322(5):438–44.

    Article  Google Scholar 

  26. Hensrud DD. Clinical preventive medicine in primary care: background and practice: 2. Delivering primary preventive services. Mayo Clin Proc. 2000;75(3):255–64.

    Article  CAS  PubMed  Google Scholar 

  27. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D, U.S. Preventive Services Task Force. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med. 2007;147(12):871–5.

    Article  PubMed  Google Scholar 

  28. Osorio M, Ravenell JE, Sevick MA, Ararso Y, Young T, Wall SP, et al. Community-based hemoglobin A1C testing in barbershops to identify black men with undiagnosed diabetes. JAMA Intern Med. 2020;180(4):596–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Earp JA, Flax VL. What lay health advisors do: an evaluation of advisors’ activities. Cancer Pract. 1999;7(1):16–21.

    Article  CAS  PubMed  Google Scholar 

  30. DeHaven MJ, Hunter IB, Wilder L, Walton JW, Berry J. Health programs in faith-based organizations: are they effective? Am J Public Health. 2004;94(6):1030–6.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Penchansky R, Thomas JW. The concept of access: definition and relationship to consumer satisfaction. Med Care. 1981;19(2):127–40.

    Article  CAS  PubMed  Google Scholar 

  32. McLaughlin CG, Wyszewianski L. Access to care: remembering old lessons. Health Serv Res. 2002;37(6):1441–3.

    Article  PubMed  Google Scholar 

  33. Nelson HD, Cantor A, Wagner J, Jungbauer R, Quiñones A, Fu R, et al. Achieving health equity in preventive services. Rockville, MD: Agency for Healthcare Research and Quality (US); 2019.

    Book  Google Scholar 

  34. Steele CB, Rim SH, Joseph DA, King JB, Seeff LC, Centers for Disease Control and Prevention (CDC). Colorectal cancer incidence and screening – United States, 2008 and 2010. MMWR Suppl. 2013;62(3):53–60.

    PubMed  Google Scholar 

  35. Adams LB, Richmond J, Corbie-Smith G, Powell W. Medical mistrust and colorectal cancer screening among African Americans. J Commun Health. 2017;42(5):1044–61.

    Article  Google Scholar 

  36. Bromley EG, May FP, Federer L, Spiegel BMR, van Oijen MGH. Explaining persistent under-use of colonoscopic cancer screening in African Americans: a systematic review. Prev Med. 2015;71:40–8.

    Article  PubMed  Google Scholar 

  37. Katz ML, James AS, Pignone MP, Hudson MA, Jackson E, Oates V, et al. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication. BMC Public Health. 2004;4:62.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Tenth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce [Internet]. [cited 2021 Oct 11]. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/tenth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services.

  39. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce [Internet]. [cited 2021 Oct 11]. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/eighth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services.

  40. Nelson HD, Cantor A, Humphrey L, Fu R, Pappas M, Daeges M, et al. Screening for breast cancer: a systematic review to update the 2009 U.S. preventive services task force recommendation. Rockville, MD: Agency for Healthcare Research and Quality (US); 2016.

    Google Scholar 

  41. Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-specific antigen-based screening for prostate cancer: a systematic evidence review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality (US); 2018.

    Book  Google Scholar 

  42. Doubeni CA, Simon M, Krist AH. Addressing systemic racism through clinical preventive service recommendations from the US Preventive Services Task Force. JAMA. 2021;325(7):627–8.

    Article  PubMed  Google Scholar 

  43. NICE International | What we do | About | NICE [Internet]. [cited 2022 Feb 12]. https://www.nice.org.uk/about/what-we-do/nice-international.

  44. Chalkidou K, Levine R, Dillon A. Helping poorer countries make locally informed health decisions. BMJ. 2010;341:c3651.

    Article  PubMed  Google Scholar 

  45. About us | Cochrane [Internet]. [cited 2022 Feb 5]. https://www.cochrane.org/about-us.

  46. About the USPSTF | United States Preventive Services Taskforce [Internet]. [cited 2022 Jan 13]. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf.

  47. Procedure Manual Section 7. Formulation of Task Force Recommendations | United States Preventive Services Taskforce [Internet]. [cited 2021 Oct 11]. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-7-formulation-task-force-recommendations.

  48. PDQ Adult Treatment Editorial Board. Non-small cell lung cancer treatment (PDQ®): health professional version. PDQ cancer information summaries. Bethesda, MD: National Cancer Institute (US); 2002.

    Google Scholar 

  49. Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e1S–e29S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962–70.

    Article  Google Scholar 

  51. Lung Cancer Statistics | How common is lung cancer? [Internet]. [cited 2021 Oct 8]. https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html.

  52. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–13.

    Article  PubMed  Google Scholar 

  53. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119(22):3976–83.

    Article  PubMed  Google Scholar 

  54. Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(10):971–87.

    Article  PubMed  Google Scholar 

  55. Zahnd WE, Eberth JM. Lung cancer screening utilization: a behavioral risk factor surveillance system analysis. Am J Prev Med. 2019;57(2):250–5.

    Article  PubMed  Google Scholar 

  56. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–7.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Breast cancer overtakes lung as most common cancer-WHO | Reuters [Internet]. [cited 2021 Oct 28]. https://www.reuters.com/article/health-cancer-int/breast-cancer-overtakes-lung-as-most-common-cancer-who-idUSKBN2A219B.

  58. How common is breast cancer? | Breast Cancer Statistics [Internet]. [cited 2021 Oct 28]. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html.

  59. Siu AL, U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279–96.

    Article  PubMed  Google Scholar 

  60. Tabár L, Dean PB, Chen TH-H, Yen AM-F, Chen SL-S, Fann JC-Y, et al. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019;125(4):515–23.

    Article  PubMed  Google Scholar 

  61. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389–99.

    Article  Google Scholar 

  62. van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156(9):609–17.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155(8):481–92.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Breast cancer risk factors | Breastcancer.org [Internet]. [cited 2021 Oct 28]. https://www.breastcancer.org/symptoms/understand_bc/risk/factors.

  65. ACS breast cancer early detection recommendations [Internet]. [cited 2021 Oct 28]. https://www.cancer.org/cancer/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html.

  66. ACOG revises breast cancer screening guidance: ob-gyns promote shared decision making | ACOG [Internet]. [cited 2021 Oct 28]. https://www.acog.org/news/news-releases/2017/06/acog-revises-breast-cancer-screening-guidance-ob-gyns-promote-shared-decision-making.

  67. Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast cancer screening for average-risk women: recommendations from the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017;14(9):1137–43.

    Article  PubMed  Google Scholar 

  68. FastStats – Leading causes of death [Internet]. [cited 2021 Oct 23]. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.

  69. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–832.

    Article  PubMed  PubMed Central  Google Scholar 

  70. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, et al. Screening for asymptomatic carotid artery stenosis: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(5):476–81.

    Article  Google Scholar 

  71. Jonas DE, Feltner C, Amick HR, Sheridan S, Zheng Z-J, Watford DJ, et al. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality (US); 2014.

    Google Scholar 

  72. Guirguis-Blake JM, Webber EM, Coppola EL. Screening for asymptomatic carotid artery stenosis in the general population: an evidence update for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality (US); 2021.

    Book  Google Scholar 

  73. Preventing stroke: healthy living habits | cdc.gov [Internet]. [cited 2022 Jan 7]. https://www.cdc.gov/stroke/healthy_living.htm.

  74. Primary, secondary and tertiary prevention [Internet]. [cited 2022 Feb 6]. https://www.iwh.on.ca/what-researchers-mean-by/primary-secondary-and-tertiary-prevention.

  75. Herman CR, Gill HK, Eng J, Fajardo LL. Screening for preclinical disease: test and disease characteristics. AJR Am J Roentgenol. 2002;179(4):825–31.

    Article  PubMed  Google Scholar 

  76. The top 10 causes of death [Internet]. [cited 2022 Feb 6]. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

  77. Hobbs FDR. Cardiovascular disease: different strategies for primary and secondary prevention? Heart. 2004;90(10):1217–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Gómez CA, Kleinman DV, Pronk N, Wrenn Gordon GL, Ochiai E, Blakey C, et al. Addressing health equity and social determinants of health through healthy people 2030. J Public Health Manag Pract. 2021;27(Suppl 6):S249–57.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Gama e Colombo D. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the Commission on Social Determinants of Health. Rev Direito Sanit. 2010;10(3):253.

    Article  Google Scholar 

  80. Davidson KW, Kemper AR, Doubeni CA, Tseng C-W, Simon MA, Kubik M, et al. Developing primary care-based recommendations for social determinants of health: methods of the U.S. Preventive Services Task Force. Ann Intern Med. 2020;173(6):461–7.

    Article  PubMed  Google Scholar 

  81. O’Gurek DT, Henke C. A practical approach to screening for social determinants of health. Fam Pract Manag. 2018;25(3):7–12.

    PubMed  Google Scholar 

  82. Centers for Medicare and Medicaid Services, Billioux A, Verlander K, Anthony S, et al. Standardized screening for health-related social needs in clinical settings: the accountable health communities screening tool. NAM Perspect. 2017;7(5).

    Google Scholar 

  83. Centers for Medicare & Medicaid Services. The accountable health communities health-related social needs screening tool. Center for Medicare and Medicaid Innovation; 2017.

    Google Scholar 

  84. AAFP PATIENT FORM (short version) social needs screening tool. https://www.aafp.org/dam/AAFP/documents/patient_care/everyone_project/patient-short-print.pdf. Accessed 2 Dec 2022.

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Erik Butler & Katrina Donahue

Authors
  1. Erik Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katrina Donahue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erik Butler .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Timothy P. Daaleman

  2. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Margaret R. Helton

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Butler, E., Donahue, K. (2023). Screening and Secondary Prevention. In: Daaleman, T.P., Helton, M.R. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-031-29171-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-29171-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-29170-8

  • Online ISBN: 978-3-031-29171-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation